Bioequivalence Test of Domestic Levetiracetam Tablets in Healthy Volunteers

DENG Ming,MA Jing-yi,MENG Ling-jie,LI Yu-qiao,GUO Yu-xiao,YI Chong-qin,LIU Hui-chen
2016-01-01
Abstract:Objective:To assess the bioequivalence of domestic levetiracetam tablets under fasting and fed conditions,and discuss the significance of the fed study and the effect of sample size on the test results.Methods:In two consecutive randomized,two-way,crossover studies,22 healthy male volunteers were given a single oral dose of 0.5 g of domestic and imported levetiracetam tablets under fasting and fed conditions,respectively.Levetiracetam in plasma were determined by LC-MS/MS method.By means of WinNonlin 6.4 software,pharmacokinetic parameters were calculated using a non-compartmental model.The 90% confidence intervals (90% CI) of the test-to-reference geometric mean ratio (GMR) of AUC and Cmax were calculated to assess the bioequivalence.Results:The 90% CI of the GMR of AUC0~t,AUC0~ ∞ and Cmax between the test and reference fell within the limits of 80.00% ~ 125.00% under fasting and fed conditions,respectively.Food did not affect the AUC or t1/2 of levetiracetam,but decreased the Cmax and delayed the Tmax.Conclusion:The domestic levetiracetam tablets were demonstrated to be equivalent to imported levetiracetam tablets under both fasting and fed conditions.The bioequivalence test of levetiracetam tablets can be conducted under only fasting conditions,and the power is sufficient for the bioequivalence assessment at the sample size of 12.
What problem does this paper attempt to address?